Salivary Transcriptome Biomarkers for Early Diabetes Detection

Status unconfirmed

Conditions studied: Pre-diabetes, Type II Diabetes, Insulin Resistance

In brief

A PRoBE design study will be used to obtain saliva from patients before undergoing blood study evaluation for screening at risk patients for the presence of undiagnosed pre-diabetes of type II diabetes. Pre-specified saliva biomarkers will be evaluated along with multi-marker models for their discriminatory value for distinguishing patients with normal glucose metabolism from those with disease. Appropriate housekeeping genes will also be incorporated to allow for the measurement of relative gene expression.

Key facts

Study ID

NCT02673762

Run by

PeriRx

People needed

180

Starts

2016-01-01

Expected to finish

2019-02-01

Last updated by the study team

2018-04-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients with unknown glucose metabolism status and
• Requiring clinically driven screening for abnormal glucose metabolism and
• Outpatient status

You may not qualify if…

• Patients on treatment for abnormal glucose metabolism including diet and drug therapy
• Patients with a prior diagnosis of abnormal glucose metabolism
• Patients on treatment with corticosteroids

Where it is running

• San Antonio Endovascular and Heart Institute — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.